Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 3
2005 2
2006 3
2007 10
2008 4
2009 4
2010 13
2011 16
2012 11
2013 6
2014 5
2015 16
2016 30
2017 27
2018 33
2019 23
2020 24
2021 10
2022 9
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Oki R, et al. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. JAMA Neurol. 2022. PMID: 35532908 Free PMC article. Clinical Trial.
Retinal Amyloid Imaging for Screening Alzheimer's Disease.
Tadokoro K, Yamashita T, Kimura S, Nomura E, Ohta Y, Omote Y, Takemoto M, Hishikawa N, Morihara R, Morizane Y, Abe K. Tadokoro K, et al. Among authors: ohta y. J Alzheimers Dis. 2021;83(2):927-934. doi: 10.3233/JAD-210327. J Alzheimers Dis. 2021. PMID: 34366344
Clinical predictors of Alzheimer's disease progression.
Hishikawa N, Fukui Y, Takemoto M, Sato K, Shang J, Yamashita T, Ohta Y, Abe K. Hishikawa N, et al. Among authors: ohta y. Geriatr Gerontol Int. 2018 Jun;18(6):929-936. doi: 10.1111/ggi.13286. Epub 2018 Mar 22. Geriatr Gerontol Int. 2018. PMID: 29569404
Potential multisystem degeneration in Asidan patients.
Ohta Y, Yamashita T, Hishikawa N, Sato K, Matsuzono K, Tsunoda K, Hatanaka N, Takemoto M, Takemi T, Takamatsu K, Abe K. Ohta Y, et al. J Neurol Sci. 2017 Feb 15;373:216-222. doi: 10.1016/j.jns.2017.01.003. Epub 2017 Jan 4. J Neurol Sci. 2017. PMID: 28131191
Antineuroinflammatory Effect of SMTP-7 in Ischemic Mice.
Huang Y, Ohta Y, Shang J, Morihara R, Nakano Y, Fukui Y, Liu X, Shi X, Feng T, Yamashita T, Sato K, Takemoto M, Hishikawa N, Suzuki E, Hasumi K, Abe K. Huang Y, et al. Among authors: ohta y. J Stroke Cerebrovasc Dis. 2018 Nov;27(11):3084-3094. doi: 10.1016/j.jstrokecerebrovasdis.2018.06.039. Epub 2018 Aug 3. J Stroke Cerebrovasc Dis. 2018. PMID: 30078758
223 results